Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism
Open accessThe DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
The conversion of testosterone into dihydrotestosterone by steroid 5 alpha-reductase is a key reaction in androgen action, and is essential both for the formation of the male phenotype during embryogenesis and for androgen-mediated growth of tissues such as the prostate. Single gene defects that impair this conversion lead to pseudohermaphroditism in which 46X,Y males have male internal urogenital tracts, but female external genitalia. We have described the isolation of a human 5 alpha-reductase complementary DNA from prostate. Subsequent cloning and genetic studies showed that this gene (designated 5 alpha-reductase 1) was normal in patients with 5 alpha-reductase deficiency. We report here the isolation of a second 5 alpha-reductase cDNA by expression cloning and the polymerase chain reaction. The biochemical and pharmacological properties of this cDNA-encoded enzyme (designated 5 alpha-reductase 2) are consistent with it being the major isozyme in genital tissue. A deletion in this gene is present in two related individuals with male pseudohermaphroditism caused by 5 alpha-reductase deficiency. These results verify the existence of at least two 5 alpha-reductases in man and provide insight into a fundamental hormone-mediated event in male sexual differentiation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Androgens and in particular the intraprostatic conversion of circulating T to DHT by SRD5A2 (Russell and Wilson, 1994) are required for normal prostate development and function (Andersson et al., 1991, Imperato-McGinley et al., 1974).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Andersson et al., 1991
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
Church, G. M., & Gilbert, W. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.7.1991 · Cited by 8,116
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,786
The Metabolic Basis of Inherited Disease
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-389_2 · Cited by 3,983
Shinozaki, K., Ohme, M., Tanaka, M., Wakasugi, T., Hayashida, N., Matsubayashi, T., Zaita, N., Chunwongse, J., Obokata, J., Yamaguchi-Shinozaki, K., et al. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04464.x · Cited by 2,403
Andersson, S., Davis, D. L., Dahlbäck, H., Jörnvall, H., & Russell, D. W. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83172-6 · Cited by 1,229
Self-citationA regulatory hierarchy for cell specialization in yeast
Herskowitz, I. (1989) · Nature · doi:10.1038/342749a0 · Cited by 590
Research works printed but not linked: 4
- Wilson, J. D. Harvey Lect. 79, 145–172 (1985).
- Wilson, J. D. Endocrinology 25, 491–508 (1975).
- Gorman, C. M., Gies, D. R. & McCray, G. DNA Prot. Engng. Tech. 2, 3–10 (1990).
- Jenkins, E. P., Andersson, S., Imperato-McGinley, J., Wilson, J. D. & Russell, D. W. J. clin. Invest. (in the press).
Cited by
Items 101–200 of 650
Bauman, D. R., Steckelbroeck, S., Williams, M. V., Peehl, D. M., & Penning, T. M. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0287 · Cited by 120
Characterization, Expression, and Immunohistochemical Localization of 5α-Reductase in Human Skin
Luu-The, V., Sugimoto, Y., Puy, L., Labrie, Y., Solache, I. L., Singh, M., & Labrie, F. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12371766 · Cited by 118
Type 1 and Type 2 5α-Reductase Expression in the Development and Progression of Prostate Cancer
Thomas, L. N., Douglas, R. C., Lazier, C. B., Too, C. K. L., Rittmaster, R. S., & Tindall, D. J. (2007) · European Urology · doi:10.1016/j.eururo.2007.10.052 · Cited by 131
The Molecular Basis of Steroid 5α-Reductase Deficiency in a Large Dominican Kindred
Thigpen, A. E., Davis, D. L., Gautier, T., Imperato-McGinley, J., & Russell, D. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210223271706 · Cited by 121
Self-citationSteroid biosynthesis and prostate cancer
Sharifi, N., & Auchus, R. J. (2012) · Steroids · doi:10.1016/j.steroids.2012.03.015 · Cited by 116
“Mutations in SRD5A2, which encodes the dominantly-expressed 5a-reductase isoenzyme in normal prostate and converts T to DHT, similarly caus pseudohermaphroditism and interfere with development, resulting in a hypoplastic prostate [52].”
Background9 Role of 5α-reductase in health and disease
Randall, V. A. (1994) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80259-9 · Cited by 140
Steroid Metabolism in the Mammalian Brain: 5Alpha-Reduction and Aromatization
Celotti, F., Negri-Cesi, P., & Poletti, A. (1997) · Brain Research Bulletin · doi:10.1016/s0361-9230(97)00216-5 · Cited by 114
Bayne, Flanagan, Einstein, Ayala, Chang, Azzolina, Whiting, Mumford, Thiboutot, Singer, et al. (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.03042.x · Cited by 112
Molecular Action of Androgen in the Normal and Neoplastic Prostate
Kokontis, J. M., & Liao, S. (1998) · Vitamins and hormones · doi:10.1016/s0083-6729(08)60937-1 · Cited by 121
Deficient H2A.Z deposition is associated with genesis of uterine leiomyoma
Berta, D. G., Kuisma, H., Välimäki, N., Räisänen, M., Jäntti, M., Pasanen, A. M., Karhu, A., Tolvanen, J., Taira, A., Cajuso, T., et al. (2021) · Nature · doi:10.1038/s41586-021-03747-1 · Cited by 115
Regulation of Sexual Dimorphism in Mammals
Haqq, C. M., & Donahoe, P. K. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.1 · Cited by 127
Yamana, K., Labrie, F., & Luu-The, V. (2010) · hmbci · doi:10.1515/hmbci.2010.035 · Cited by 105
The evolving role of genetic tests in reproductive medicine
Cariati, F., D’Argenio, V., & Tomaiuolo, R. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2019-8 · Cited by 116
THIBOUTOT, D. M., KNAGGS, H., GILLILAND, K., & HAGARI, S. (1997) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1997.d01-1162.x · Cited by 109
5α‐Reductase Isozymes and Androgen Actions in the Prostate
Zhu, Y., & Imperato‐McGinley, J. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04115.x · Cited by 116
Melcangi, R. C., Celotti, F., & Martini, L. (1994) · Brain Research · doi:10.1016/0006-8993(94)91731-0 · Cited by 113
11β‐hydroxysteroid dehydrogenase isoforms and their implications for blood pressure regulation
SECKL, J. R. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00720.x · Cited by 105
Differential expression of 5α-reductase isoenzymes in the human prostate and prostatic carcinomas
Bonkhoff, H., Stein, U., Aumüller, G., & Remberger, K. (1996) · The Prostate · doi:10.1002/(sici)1097-0045(199610)29:4<261::aid-pros7>3.0.co;2-e · Cited by 106
Azzolina, B., Ellsworth, K. P., Andersson, S., Geissler, W. M., Bull, H. G., & Harris, G. S. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00002-2 · Cited by 115
Self-citationOgino, Y., Katoh, H., & Yamada, G. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.08.046 · Cited by 103
5α-Reductase Activity in Women with Polycystic Ovary Syndrome1
Jakimiuk, A. J., Weitsman, S. R., & Magoffin, D. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.7.5863 · Cited by 97
Steroidogenic Enzymes in the Brain: Morphological Aspects
Pelletier, G. (2010) · Progress in brain research · doi:10.1016/s0079-6123(08)81011-4 · Cited by 109
Molecular biology of androgen insensitivity
Jääskeläinen, J. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.08.006 · Cited by 110
“There are several steps in androgen biosynthesis but 17-HSD3 deficiency, where the final step in testosterone biosynthesis from androstenedione to T is impaired, may be especially challenging to diagnose (Andersson et al., 1991).”
Clinical biochemistry of dihydrotestosterone
Marchetti, P. M., & Barth, J. H. (2013) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2012.012159 · Cited by 114
7α-Methyl-19-Nortestosterone Maintains Sexual Behavior and Mood in Hypogonadal Men*
Anderson, R. A., Martin, C. W., Kung, A. W. C., Everington, D., Pun, T. C., Tan, K. C. B., Bancroft, J., Sundaram, K., Moo-Young, A. J., & Baird, D. T. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6028 · Cited by 97
Immunohistochemical evidence for differential distribution of 5α-reductase isoenzymes in human skin
EICHELER, W., DREHER, M., HOFFMANN, R., HAPPLE, R., & AUMULLER, G. (1995) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1995.tb02663.x · Cited by 100
Aging in peripheral nerves: regulation of myelin protein genes by steroid hormones
Melcangi, R. C., Magnaghi, V., & Martini, L. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00028-3 · Cited by 102
Mechanisms of Androgen Receptor Activation in Castration-Resistant Prostate Cancer
Sharifi, N. (2013) · Endocrinology · doi:10.1210/en.2013-1466 · Cited by 108
Estrogen and Progesterone Metabolism in the Cervix during Pregnancy and Parturition
Andersson, S., Minjarez, D., Yost, N. P., & Word, R. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2813 · Cited by 94
Self-citationNeurogenic Pain and Steroid Synthesis in the Spinal Cord
Patte‐Mensah, C., Kibaly, C., Boudard, D. L., Schaeffer, V., Béglé, A., Saredi, S., Meyer, L., & Mensah‐Nyagan, A. G. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:28:1:17 · Cited by 103
“The 5αR2 gene is expressed mainly in the prostate and gonads, and its deletion provokes male pseudohermaphroditism (Andersson et al., 1991; Thigpen et al., 1993; Luu-The et al., 1994; Mowszowicz et al., 1995).”
BackgroundFinasteride in the treatment of alopecia
Libecco, J. F., & Bergfeld, W. F. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.4.933 · Cited by 95
“Observations in patients with congenitally absent 5α-R Type II activity did not demonstrate AGA with ageing and had sparse body hair [4,5].”
BackgroundGenetic dissection of mammalian fertility pathways
Matzuk, M. M., & Lamb, D. J. (2002) · Nature Medicine · doi:10.1038/nm-fertilitys41 · Cited by 95
Promotion of Hair Growth by Rosmarinus officinalis Leaf Extract
Murata, K., Noguchi, K., Kondo, M., Onishi, M., Watanabe, N., Okamura, K., & Matsuda, H. (2012) · Phytotherapy Research · doi:10.1002/ptr.4712 · Cited by 95
“Two isozymes have been characterized for 5aR, which are types I and II (Andersson et al., 1991).”
BackgroundBranching morphogenesis in the prostate gland and seminal vesicles
Thomson, A. A., & Marker, P. C. (2006) · Differentiation · doi:10.1111/j.1432-0436.2006.00101.x · Cited by 96
Molecular Mechanisms of Androgen Action – A Historical Perspective
Brinkmann, A. O. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-61779-243-4_1 · Cited by 83
Evolution of steroid-5α-reductases and comparison of their function with 5β-reductase
Langlois, V. S., Zhang, D., Cooke, G. M., & Trudeau, V. L. (2009) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2009.08.004 · Cited by 106
Lan, Z., Labus, J. C., & Hinton, B. T. (1998) · Biology of Reproduction · doi:10.1095/biolreprod58.1.197 · Cited by 92
5α-Reductase Type 1 Modulates Insulin Sensitivity in Men
Upreti, R., Hughes, K. A., Livingstone, D. E. W., Gray, C. D., Minns, F. C., Macfarlane, D. P., Marshall, I., Stewart, L. H., Walker, B. R., & Andrew, R. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1395 · Cited by 91
Kinniburgh, D. W., Anderson, R. A., & Baird, D. T. (2001) · Journal of Andrology · doi:10.1002/j.1939-4640.2001.tb02157.x · Cited by 90
Thigpen, A. E., & Russell, D. W. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42482-9 · Cited by 94
Self-citationThe V89L polymorphism in the 5alpha-reductase type 2 gene and risk of prostate cancer.
Febbo, P. G., Kantoff, P. W., Platz, E. A., Casey, D., Batter, S., Giovannucci, E. L., Hennekens, C. H., & Stampfer, M. J. (1999) · PubMed · Cited by 102
Agis-Balboa, R. C., Guidotti, A., & Pinna, G. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3567-5 · Cited by 89
“…isozymes encoded by two distinct genes, designated type I and type II, have been identified in rodents (Berman and Russell 1993; Mahendroo et al. 1996; Normington and Russell 1992), monkeys (Levy et al. 1995), and humans (Andersson et al. 1991; Labrie et al. 1992; Russell and Wilson 1994).”
SURGICAL TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA
Schnitzer, J. J., & Donahoe, P. K. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70023-9 · Cited by 89
Patte‐Mensah, C., Penning, T. M., & Mensah‐Nyagan, A. G. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20251 · Cited by 86
“R, type 1 (5 -R1) and type 2 (5 -R2), have been cloned in humans and rat (Andersson and Russell, 1990; Andersson et al., 1991; Berman and Russell, 1993).”
BackgroundDélos, S., Iehlé, C., Martin, P., & Raynaud, J. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90074-4 · Cited by 89
Expression of androgen receptor and 5α‐reductases in the human normal endometrium and its disorders
Ito, K., Suzuki, T., Akahira, J., Moriya, T., Kaneko, C., Utsunomiya, H., Yaegashi, N., Okamura, K., & Sasano, H. (2002) · International Journal of Cancer · doi:10.1002/ijc.10394 · Cited by 88
Androgen and progesterone metabolism in the central and peripheral nervous system
Martini, L., Melcangi, R. C., & Maggi, R. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90075-8 · Cited by 88
AMI, S. I., RATA, S. K., NODA, T. S., & KAYASU, S. T. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1995.tb08706.x · Cited by 86
The Critical Role of Androgens in Prostate Development
Wilson, J. D. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.05.003 · Cited by 101
5α-Reduced C21 steroids are substrates for human cytochrome P450c17
Gupta, M. K., Guryev, O. L., & Auchus, R. J. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.07.003 · Cited by 84
Chen, W., Zouboulis, C. C., Fritsch, M., Blume‐Peytavi, U., Kodelja, V., Goerdt, S., Luu-The, V., & Orfanos, C. E. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00080.x · Cited by 84
Levy, M. A., Brandt, M. A., Sheedy, K. M., Holt, D. A., Heaslip, J. I., Trill, J. J., Ryan, P. J., Morris, R. A., Garrison, L. M., & Bergsma, D. J. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)00183-m · Cited by 92
Barbaro, M., Cicognani, A., Balsamo, A., Löfgren, Å., Baldazzi, L., Wedell, A., & Oscarson, M. (2008) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.00980.x · Cited by 88
5-Alpha reductase deficiency: a 40-year retrospective review
Okeigwe, I., & Kuohung, W. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000116 · Cited by 78
“Their findings confirmed 5-alpha reductase deficiency as the cause of each individual’s manifestation of the disorder [14].”
BackgroundMetabolic conversion as a pre‐receptor control mechanism for lipophilic hormones
Nobel, S., Abrahmsen, L., & Oppermann, U. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02359.x · Cited by 80
Negri‐Cesi, P., Poletti, A., & Celotti, F. (1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(96)00083-0 · Cited by 87
Wang, H., Zhang, L., Wang, N., Zhu, H., Han, B., Sun, F., Yao, H., Zhang, Q., Zhu, W., Cheng, T., et al. (2018) · Human Genetics · doi:10.1007/s00439-018-1879-y · Cited by 88
Fruzzetti, F., Bersi, C., Parrini, D., Ricci, C., & Genazzani, A. R. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00486-5 · Cited by 80
Minireview: Androgen Metabolism in Castration-Resistant Prostate Cancer
Sharifi, N. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1007 · Cited by 76
Ciotta, L., Cianci, A., Calogero, A. E., Palumbo, M. A., Marletta, E., Sciuto, A., & Palumbo, G. A. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57727-9 · Cited by 78
Walter, K. N., Kienzle, F., Frankenschmidt, A., Hiort, O., Wudy, S. A., van der Werf-Grohmann, N., Superti‐Furga, A., & Schwab, K. O. (2010) · Hormone Research in Paediatrics · doi:10.1159/000313372 · Cited by 78
Chen, X., Liu, B., Li, Y., Han, L., Tang, X., Deng, W., Lai, W., & Wan, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01528 · Cited by 79
“Male pseudohermaphroditism patients show nearly no beard growth or AGAhair loss because of a lack of 5aR2, which suggests thatDHT is necessary for beard growth (Andersson et al., 1991; Adachi et al., 2000; Jakubiczka, 2015).”
BackgroundMolecular Characterization of 5 -Reductase Type 2 Deficiency and Fertility in a Swedish Family
Nordenskjöld, A., & Ivarsson, S.-A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5125 · Cited by 78
Weißer, H., Tunn, S., Behnke, B., & Krieg, M. (1996) · The Prostate · doi:10.1002/(sici)1097-0045(199605)28:5<300::aid-pros5>3.0.co;2-f · Cited by 77
Characterization of 5α-reductase gene expression in stroma and epithelium of human prostate
Bruchovsky, N., Sadar, M. D., Akakura, K., Goldenberg, S. L., Matsuoka, K., & Rennie, P. S. (1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(96)00125-2 · Cited by 83
Strautnieks, S. S., Thompson, R. J., Hanukoglu, A., Dillon, M. J., Hanukoglu, I., Kuhnle, U., Seckl, J. R., Gardiner, R. M., & Chung, E. M. K. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.2.293 · Cited by 83
Finasteride: A slow-binding 5.alpha.-reductase inhibitor
Faller, B., Farley, D., & Nick, H. (1993) · Biochemistry · doi:10.1021/bi00072a028 · Cited by 76
Effect of finasteride, a 5 alpha-reductase inhibitor, on serum gonadotropins in normal men
Rittmaster, R. S. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.2.484 · Cited by 75
Crystal structure of steroid reductase SRD5A reveals conserved steroid reduction mechanism
Han, Y., Zhuang, Q., Sun, B., Lv, W., Wang, S., Xiao, Q., Pang, B., Zhou, Y., Wang, F., Chi, P., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20675-2 · Cited by 63
5α-Reductases in Human Breast Carcinoma: Possible Modulator of in Situ Androgenic Actions1
Suzuki, T., Darnel, A. D., Akahira, J.-I., Ariga, N., Ogawa, S., Kaneko, C., Takeyama, J., Moriya, T., & Sasano, H. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7444 · Cited by 72
The androgen receptor: a potential target for therapy of prostate cancer
dos Santos, A. F., Huang, H., & Tindall, D. J. (2003) · Steroids · doi:10.1016/j.steroids.2003.10.005 · Cited by 82
Muthusamy, S., Andersson, S., Kim, H.-J., Butler, R., Waage, L., Bergerheim, U., & Gustafsson, J.-Å. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117772108 · Cited by 72
Self-citation46,XY DSD due to impaired androgen production
Mendonca, B. B., Costa, E. M. F., Belgorosky, A., Rivarola, M. A., & Domenice, S. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.11.003 · Cited by 78
Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism
Şahin, Y., Dilber, S., & Keleştimur, F. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01764-7 · Cited by 73
Asada, Y., Sonoda, T., Ojiro, M., Kurata, S., Sato, T., Ezaki, T., & Takayasu, S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7545 · Cited by 72
Mizokami, A., Koh, E., Izumi, K., Narimoto, K., Takeda, M., Honma, S., Dai, J., Keller, E. T., & Namiki, M. (2009) · Endocrine-Related Cancer · doi:10.1677/erc-09-0070 · Cited by 72
“Testosterone is then converted to DHT by 5a-steroid reductase (SRD5A) in the prostate (Andersson & Russell 1990, Andersson et al. 1991, Labrie et al. 2005, Luu-The et al. 2008).”
BackgroundBauman, D. R., Steckelbroeck, S., Peehl, D. M., & Penning, T. M. (2006) · Endocrinology · doi:10.1210/en.2006-0627 · Cited by 72
In planta induced genes of Puccinia triticina
Thara, V. K., Fellers, J. P., & Zhou, J. (2002) · Molecular Plant Pathology · doi:10.1046/j.1364-3703.2003.00142.x · Cited by 69
Genetic regulation of androgen action
Kallio, P. J., Palvimo, J. J., & Jänne, O. A. (1996) · The Prostate · doi:10.1002/(sici)1097-0045(1996)6+<52::aid-pros10>3.0.co;2-q · Cited by 19
Elo, J. P., Akinola, L. A., Poutanen, M., Vihko, P., Kyllönen, A. P., Lukkarinen, O., & Vihko, R. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960328)66:1<37::aid-ijc7>3.0.co;2-# · Cited by 69
Formation and effects of neuroactive steroids in the central and peripheral nervous system
Melcangi, R. C., Magnaghi, V., Galbiati, M., & Martini, L. (2001) · International review of neurobiology · doi:10.1016/s0074-7742(01)46062-4 · Cited by 71
Hoffmann, R. (2002) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2002.01086.x · Cited by 68
The Molecular Genetics of Steroid 5α-Reductases
Russell, D. W., Berman, D. M., BRYANT, J. T., Cala, K. M., Davis, D. L., Landrum, C. P., Prihoda, J. S., Silver, R. I., Thigpen, A. E., & Wigley, W. C. (1994) · Elsevier eBooks · doi:10.1016/b978-0-12-571149-4.50018-0 · Cited by 89
Self-citationThe enzyme and inhibitors of 4-ene-3-oxosteroid 5α-oxidoreductase
Li, X., Chen, C., Singh, S. M., & Labire, F. (1995) · Steroids · doi:10.1016/0039-128x(95)00021-h · Cited by 73
Langlois, V. S., Duarte‐Guterman, P., Ing, S., Pauli, B. D., Cooke, G. M., & Trudeau, V. L. (2009) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2009.11.004 · Cited by 69
Ando, Y., Yamaguchi, Y., Hamada, K., Yoshikawa, K., & Itami, S. (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.03156.x · Cited by 66
Liu, J., Kurashiki, K., Shimizu, K., & Kondo, R. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.08.018 · Cited by 65
History of weight and obesity through life and risk of benign prostatic hyperplasia
Zucchetto, A., Tavani, A., Maso, L. D., Gallus, S., Negri, E., Talamini, R., Franceschi, S., Montella, M., & Vecchia, C. L. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802979 · Cited by 74
Steroidogenic gene expression during sex determination in the frog Rana rugosa
Maruo, K., Suda, M., Yokoyama, S., Oshima, Y., & Nakamura, M. (2008) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2008.04.019 · Cited by 65
Falsetti, L., Gambera, A., Andrico, S., & Sartori, E. (2002) · Gynecological Endocrinology · doi:10.1080/713603096 · Cited by 65
Schaeffer, V., Meyer, L., Patte‐Mensah, C., & Mensah‐Nyagan, A. G. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.009 · Cited by 73
Stoffel‐Wagner, B., Beyenburg, S., Watzka, M., Blümcke, I., Bauer, J., Schramm, J., Bidlingmaier, F., & Elger, C. E. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00133.x · Cited by 62
Mazen, I., Gad, Y. Z., Hafez, M. M., Sultan, C., & Lumbroso, S. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01763.x · Cited by 63
Association of Benign Prostatic Hyperplasia with Male Pattern Baldness
Oh, B. R., Kim, S., Moon, J. D., Kim, H. N., Kwon, D. D., Won, Y. H., Ryu, S. B., & Park, Y. I. (1998) · Urology · doi:10.1016/s0090-4295(98)00108-3 · Cited by 62
5 alpha-reductase-2 gene mutations in the Dominican Republic
Cai, L. Q. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.5.1730 · Cited by 62
Embryonic development of mouse external genitalia: insights into a unique mode of organogenesis
Suzuki, K., Ogino, Y., Murakami, R., Satoh, Y., Bachiller, D., & Yamada, G. (2002) · Evolution & Development · doi:10.1046/j.1525-142x.2002.01061.x · Cited by 62
“The 5 -reductase isozymes are expressed in external genitalia (Tian and Russell 1997), and a lack of these enzymes results in syndromes in which hypospadias, a common congenital anomaly in humans (Andersson et al. 1991; van der Werff et al. 1997; Wilson 1992), is displayed.”
BackgroundBoehmer, A. L. M., Brinkmann, A. O., Nijman, R. J. M., Verleun-Mooijman, M. C. T., de Ruiter, P. E., Niermeijer, M. F., & Drop, S. L. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7333 · Cited by 62
“This codon is either CTA or GTA with unknown allele frequencies (29, 30).”
BackgroundKatz, M. D. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.11.3160 · Cited by 63
LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
Hirsch, K. S., Jones, C. D., Audia, J. E., Andersson, S., McQuaid, L. A., Stamm, N. B., Neubauer, B. L., Pennington, P., Toomey, R. E., & Russell, D. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5277 · Cited by 62
Self-citationHirosumi, J., Nakayama, O., Fagan, T., SAWADA, K., Chida, N., Inami, M., Takahashi, S., Kojo, H., Notsu, Y., & OKUHARA, M. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)00187-q · Cited by 65
Metadata
- Authors
- Andersson, S., Berman, D. M., Jenkins, E. P., & Russell, D. W.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- Nature
- Published
- 1991-11
- Volume
- 354
- Issue
- 6349
- Pages
- 159-161
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4451825
- OpenAlex
- W2058387263
- Cited by
- 643
- References
- 29
- Citations by year
- 2026: 9 · 2025: 3 · 2024: 6 · 2023: 13 · 2022: 8 · 2021: 14 · 2020: 13 · 2019: 7 · 2018: 11 · 2017: 9 · 2016: 11 · 2015: 14 · 2014: 9 · 2013: 13 · 2012: 15
- FWCI
- 8.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL020948)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Health Sciences › Medicine › Urology › Urological Disorders and Treatments
- Keywords
- 5-alpha-reductase deficiency, 46,XY disorders of sex development, dihydrotestosterone, androgen action, male sexual differentiation, gene deletion, cDNA cloning, isozymes, prostate
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Genes, Humans, Hydrogen-Ion Concentration, Isoenzymes, Molecular Sequence Data, Disorders of Sex Development, 3-Oxo-5-alpha-Steroid 4-Dehydrogenase, Blotting, Southern, Sequence Alignment, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.